Showing results (6671-6680 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 7, 2006
Alpha2-antiplasmin on cardiovascular diseasesHiroyuki MatsunoCurrent Pharmaceutical Design|November 15, 2006
Evolution of a "conserved" amino acid sequence: a model study of an in silico investigation of the phylogenesis of some immune receptorsM A Panaro, A Acquafredda, M Sisto, et al.Current Pharmaceutical Design|November 15, 2006
Negative regulators of toll-like receptor 4-mediated macrophage inflammatory responseJonathan P Butchar, Kishore V L Parsa, Clay B Marsh, et al.Current Pharmaceutical Design|November 15, 2006
Toll-like receptors in human infectious diseasesS de la Barrera, M Alemán, M del C SasiainCurrent Pharmaceutical Design|November 15, 2006
Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarizationLuigi Amati, Maria Pepe, Maria Elena Passeri, et al.Current Pharmaceutical Design|December 16, 2006
Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatmentSalvador Rodriguez-Nieto, Boris ZhivotovskyCurrent Pharmaceutical Design|December 16, 2006
The redox regulation of thiol dependent signaling pathways in cancerGregory I GilesCurrent Pharmaceutical Design|December 16, 2006
G protein-activated inwardly rectifying potassium channels as potential therapeutic targetsToru Kobayashi, Kazutaka IkedaCurrent Pharmaceutical Design|December 16, 2006
Nitrergic modulation of gastrointestinal function during early endotoxemiaE Quintana, M D Barrachina, J V EspluguesCurrent Pharmaceutical Design|December 16, 2006
Bioinformatics research on the SARS coronavirus (SARS_CoV) in ChinaPei Hao, Min Chen, Guoqing Zhang, et al.Pageof 1,008